The Paradigm Shift of Ophthalmology in the COVID-19 Era

References

• Holz FG, Tadayoni R, Beatty S, et al. Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration. Br J Ophthalmol. 2015;99(2):220–226. doi:10.1136/bjophthalmol-2014-305327
   PubMed Web of Science ®Google Scholar
• Pieramici DJ, Wang PW, Ding B, Gune S. Visual and anatomic outcomes in patients with diabetic macular edema with limited initial anatomic response to ranibizumab in RIDE and RISE. Ophthalmology. 2016;123(6):1345–1350. doi:10.1016/j.ophtha.2016.02.007
   PubMed Web of Science ®Google Scholar
• Prunte C, Fajnkuchen F, Mahmood S, et al. Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study. Br J Ophthalmol. 2016;100(6):787–795. doi:10.1136/bjophthalmol-2015-307249
   PubMed Web of Science ®Google Scholar
• Brown DM, Campochiaro PA, Bhisitkul RB, et al. Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a Phase III study. Ophthalmology. 2011;118(8):1594–1602. doi:10.1016/j.ophtha.2011.02.022
   PubMed Web of Science ®Google Scholar
• Campochiaro PA, Brown DM, Awh CC, et al. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study. Ophthalmology. 2011;118(10):2041–2049. doi:10.1016/j.ophtha.2011.02.038
   PubMed Web of Science ®Google Scholar
• Nguyen AX, Gervasio KA, Wu AY. Differences in SARS-CoV-2 recommendations from major ophthalmology societies worldwide. BMJ Open Ophthalmology. 2020;5:e000525. doi:10.1136/bmjophth-2020-000525
   Google Scholar
• Lai THT, Tang EWH, Chau SKY, Fung KSC, Li KKW. Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong. Graefes Arch Clin Exp Ophthalmol. 2020;258(5):1049–1055. doi:10.1007/s00417-020-04641-8
   PubMed Web of Science ®Google Scholar
• Hu VH, Watts E, Burton M, et al. Protecting yourself and your patients from COVID-19 in eye care. Community Eye Health. 2020;33(108):S1–S6.
   Google Scholar
• Chu DK, Akl EA, Duda S, et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. 2020;395(10242):1973–1987. doi:10.1016/S0140-6736(20)31142-9
   PubMed Web of Science ®Google Scholar
• Korobelnik JF, Loewenstein A, Eldem B, et al. Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic. Graefes Arch Clin Exp Ophthalmol. 2020;258(6):1149–1156. doi:10.1007/s00417-020-04703-x
   PubMed Web of Science ®Google Scholar
• Li JPO, Shantha J, et al. Preparedness among Ophthalmologists: during and Beyond the COVID-19 pandemic. Ophthalmology. 2020;127(5):569–572. doi:10.1016/j.ophtha.2020.03.037
   PubMed Web of Science ®Google Scholar
• Pei X, Jiao X, Lu D, Qi D, Huang S, Li Z. How to face COVID-19 in ophthalmology practice. Med Hypothesis Discov Innov Ophthalmol. 2020;9(3):164–171.
   Google Scholar
• Schmidt-Erfurth U, Garcia-Arumi J, Gerendas BS, et al. Guidelines for the management of retinal vein occlusion by the European Society of Retina Specialists (EURETINA). Ophthalmologica. 2019;242(3):123–162. doi:10.1159/000502041
   PubMed Web of Science ®Google Scholar
• Seah IYJ, Anderson DE, Kang AEZ, et al. Assessing viral shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients. Ophthalmology. 2020;127(7):977–979. doi:10.1016/j.ophtha.2020.03.026
   PubMed Web of Science ®Google Scholar
• Peng Y, Zhou YH. Is novel coronavirus disease (COVID-19) transmitted through conjunctiva? J Med Virol. 2020;92(9):1408–1409. doi:10.1002/jmv.25753
   PubMed Web of Science ®Google Scholar
• Larsen M, Waldstein SM, Boscia F, et al. Individualized ranibizumab regimen driven by stabilization criteria for central retinal vein occlusion: twelve-month results of the CRYSTAL study. Ophthalmology. 2016;123(5):1101–1111. doi:10.1016/j.ophtha.2016.01.011
   PubMed Web of Science ®Google Scholar
• Tadayoni R, Waldstein SM, Boscia F, et al. Sustained benefits of ranibizumab with or without laser in branch retinal vein occlusion: 24-month results of the BRIGHTER study. [published correction appears in Ophthalmology. 2018 Mar;125(3):463]. Ophthalmology. 2017;124(12):1778–1787. doi:10.1016/j.ophtha.2017.06.027
   PubMed Web of Science ®Google Scholar
• Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419–1431. doi:10.1056/NEJMoa054481
   PubMed Web of Science ®Google Scholar
• Wecker T, Grundel B, Reichl S, et al. Anti-VEGF injection frequency correlates with visual acuity outcomes in pro re nata neovascular AMD treatment. Sci Rep. 2019;9:3301. doi:10.1038/s41598-019-38934-8
   PubMed Web of Science ®Google Scholar
• Ashraf M, Souka A, Adelman R. Predicting outcomes to anti-vascular endothelial growth factor (VEGF) therapy in diabetic macular oedema: a review of the literature. Br J Ophthalmol. 2016;100(12):1596–1604. doi:10.1136/bjophthalmol-2016-308388
   PubMed Web of Science ®Google Scholar
• Schmidt-Erfurth U, Garcia-Arumi J, Bandello F, et al. Guidelines for the management of diabetic macular edema by the European Society of Retina Specialists (EURETINA). Ophthalmologica. 2017;237(4):185–222. doi:10.1159/000458539
   PubMed Web of Science ®Google Scholar
• Koshy ZR, Dickie D. Aerosol generation from high speed ophthalmic instrumentation and the risk of contamination from SARS COVID19. Eye. 2020. doi:10.1038/s41433-020-1000-3
   Web of Science ®Google Scholar
• Zhou Y, Duan C, Zeng Y, et al. Ocular findings and proportion with conjunctival SARS-COV-2 in COVID-19 Patients. Ophthalmology. 2020;127(7):982–983. doi:10.1016/j.ophtha.2020.04.028
   PubMed Web of Science ®Google Scholar
• Patel R, Babady E, Theel ES, et al. Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: value of Diagnostic Testing for SARS-CoV-2/COVID-19. mBio. 2020;11(2):e00722–00720. doi:10.1128/mBio.00722-20
   Web of Science ®Google Scholar
• Al-Muharraqi MA. Testing recommendation for COVID-19 (SARS-CoV-2) in patients planned for surgery - continuing the service and ‘suppressing’ the pandemic. Br J Oral Maxillofac Surg. 2020;58(5):503–505. doi:10.1016/j.bjoms.2020.04.014
   Web of Science ®Google Scholar
• Carmo A, Pereira-Vaz J, Mota V, et al. Clearance and persistence of SARS-CoV-2 RNA in patients with COVID-19. J Med Virol. 2020:1–5. doi:10.1002/jmv.26103.
   Web of Science ®Google Scholar
• Li R, Pei S, Chen B, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science. 2020;368(6490):489–493. doi:10.1126/science.abb3221
   PubMed Web of Science ®Google Scholar
• Gharebaghi R, Desuatels J, Moshirfar M, Parvizi M, Daryabari SH, Heidary F. COVID-19: preliminary clinical guidelines for ophthalmology practices. Med Hypothesis Discov Innov Ophthalmol. 2020;9(2):149–158.
   PubMedGoogle Scholar
• Parrish RK 2nd, Stewart MW, Duncan Powers SL. Ophthalmologists are more than eye doctors-in memoriam Li Wenliang. Am J Ophthalmol. 2020;213:A1–A2. doi:10.1016/j.ajo.2020.02.014
   Web of Science ®Google Scholar
• Green A. Li Wenliang. Lancet. 2020;395(10225):682. doi:10.1016/S0140-6736(20)30382-2
   Web of Science ®Google Scholar
• Liu Y, Yan L-M, Wan L, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020;20(6):656–657. doi:10.1016/S1473-3099(20)30232-2
   PubMed Web of Science ®Google Scholar